Chronic Kidney Disease Management
Learn about FDA-approved drugs that may delay or halt progression of chronic kidney disease.
About this course
This course provides 1 AMA PRA Category 1 Credits for license renewal. Chronic kidney disease is an important public health issue, and there is a significant unmet need for therapies that slow disease progression and improve outcomes. Early diagnosis and treatment of the underlying cause and/or the institution of secondary preventive measures are imperative in patients with chronic kidney disease (CKD). This activity focuses on the efficacy and safety of FDA-approved drugs that may delay, or possibly halt, progression of the disease.
Course Accreditation
This course is approved for the following professions. You can get more details on each profession by clicking on it.
Faculty
InstructorsYou might also be interested in
What are others saying?
Take a look at what other healthcare professionals are saying about AchieveCE’s continuing education courses.
Requirements
Participants must score a passing grade of 70% or higher on the activity post-test and complete an activity evaluation. There are no time limits and unlimited test-taking attempts. Credits will be reported automatically to CE Broker if your license information is entered properly in your profile.
- Windows 8.1
- Windows 10
- Mac OS X 10.1+
- iOS 10+
- Android 4.3+
- Google Chrome
- Microsft Edge
- Mozilla Firefox
- Adobe Acrobat Reader
- Broadband Internet Connection: T1
- Hi-speed DSL or Cable4G cellular connection